203 related articles for article (PubMed ID: 22990145)
1. EMQN/CMGS best practice guidelines for the molecular genetic testing of Huntington disease.
Losekoot M; van Belzen MJ; Seneca S; Bauer P; Stenhouse SA; Barton DE;
Eur J Hum Genet; 2013 May; 21(5):480-6. PubMed ID: 22990145
[TBL] [Abstract][Full Text] [Related]
2. Huntington Disease: Molecular Diagnostics Approach.
Bastepe M; Xin W
Curr Protoc Hum Genet; 2015 Oct; 87():9.26.1-9.26.23. PubMed ID: 26439718
[TBL] [Abstract][Full Text] [Related]
3. Assessing the analytic validity of molecular testing for Huntington disease using data from an external proficiency testing survey.
Palomaki GE; Richards CS
Genet Med; 2012 Jan; 14(1):69-75. PubMed ID: 22237433
[TBL] [Abstract][Full Text] [Related]
4. Discrepancies in reporting the CAG repeat lengths for Huntington's disease.
Quarrell OW; Handley O; O'Donovan K; Dumoulin C; Ramos-Arroyo M; Biunno I; Bauer P; Kline M; Landwehrmeyer GB;
Eur J Hum Genet; 2012 Jan; 20(1):20-6. PubMed ID: 21811303
[TBL] [Abstract][Full Text] [Related]
5. Robust Preimplantation Genetic Testing of Huntington Disease by Combined Triplet-Primed PCR Analysis of the HTT CAG Repeat and Multi-Microsatellite Haplotyping.
Zhao M; Cheah FSH; Tan ASC; Lian M; Phang GP; Agarwal A; Chong SS
Sci Rep; 2019 Nov; 9(1):16481. PubMed ID: 31712634
[TBL] [Abstract][Full Text] [Related]
6. Expanding the Spectrum of Genes Involved in Huntington Disease Using a Combined Clinical and Genetic Approach.
Mariani LL; Tesson C; Charles P; Cazeneuve C; Hahn V; Youssov K; Freeman L; Grabli D; Roze E; Noël S; Peuvion JN; Bachoud-Levi AC; Brice A; Stevanin G; Durr A
JAMA Neurol; 2016 Sep; 73(9):1105-14. PubMed ID: 27400454
[TBL] [Abstract][Full Text] [Related]
7. An intergenerational contraction of a fully penetrant Huntington disease allele to a reduced penetrance allele: interpretation of results and significance for risk assessment and genetic counseling.
Nahhas F; Garbern J; Feely S; Feldman GL
Am J Med Genet A; 2009 Feb; 149A(4):732-6. PubMed ID: 19267413
[TBL] [Abstract][Full Text] [Related]
8. Null alleles at the Huntington disease locus: implications for diagnostics and CAG repeat instability.
Williams LC; Hegde MR; Nagappan R; Faull RL; Giles J; Winship I; Snow K; Love DR
Genet Test; 2000; 4(1):55-60. PubMed ID: 10794362
[TBL] [Abstract][Full Text] [Related]
9. A new mutation for Huntington disease following maternal transmission of an intermediate allele.
Semaka A; Kay C; Belfroid RD; Bijlsma EK; Losekoot M; van Langen IM; van Maarle MC; Oosterloo M; Hayden MR; van Belzen MJ
Eur J Med Genet; 2015 Jan; 58(1):28-30. PubMed ID: 25464109
[TBL] [Abstract][Full Text] [Related]
10. A genetic association study of glutamine-encoding DNA sequence structures, somatic CAG expansion, and DNA repair gene variants, with Huntington disease clinical outcomes.
Ciosi M; Maxwell A; Cumming SA; Hensman Moss DJ; Alshammari AM; Flower MD; Durr A; Leavitt BR; Roos RAC; ; ; Holmans P; Jones L; Langbehn DR; Kwak S; Tabrizi SJ; Monckton DG
EBioMedicine; 2019 Oct; 48():568-580. PubMed ID: 31607598
[TBL] [Abstract][Full Text] [Related]
11. XL PCR for the detection of large trinucleotide expansions in juvenile Huntington's disease.
Milunsky JM; Maher TA; Loose BA; Darras BT; Ito M
Clin Genet; 2003 Jul; 64(1):70-3. PubMed ID: 12791042
[TBL] [Abstract][Full Text] [Related]
12. Patterns of meiotic variability of the (CAG)n repeat in the Huntington disease gene.
Lucotte G; Gérard N; Aouizérate A; Loirat F; Hazout S
Genet Couns; 1997; 8(2):77-81. PubMed ID: 9219003
[TBL] [Abstract][Full Text] [Related]
13. A Novel Triplet-Primed PCR Assay to Detect the Full Range of Trinucleotide CAG Repeats in the Huntingtin Gene (
De Luca A; Morella A; Consoli F; Fanelli S; Thibert JR; Statt S; Latham GJ; Squitieri F
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33567536
[TBL] [Abstract][Full Text] [Related]
14. Autopsy-proven Huntington's disease with 29 trinucleotide repeats.
Kenney C; Powell S; Jankovic J
Mov Disord; 2007 Jan; 22(1):127-30. PubMed ID: 17115386
[TBL] [Abstract][Full Text] [Related]
15. Investigations of Huntington's Disease and Huntington's Disease-Like Syndromes in Indian Choreatic Patients.
Kaur J; Parveen S; Shamim U; Sharma P; Suroliya V; Sonkar AK; Ahmad I; Garg J; Anand KS; Laskar S; Chowdhury D; Kushwaha S; Goyal V; Srivastava AK; Singh G; Faruq M
J Huntingtons Dis; 2020; 9(3):283-289. PubMed ID: 32675418
[TBL] [Abstract][Full Text] [Related]
16. Single-step scalable-throughput molecular screening for Huntington disease.
Teo CR; Wang W; Yang Law H; Lee CG; Chong SS
Clin Chem; 2008 Jun; 54(6):964-72. PubMed ID: 18403567
[TBL] [Abstract][Full Text] [Related]
17. EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency.
Baumgartner-Parzer S; Witsch-Baumgartner M; Hoeppner W
Eur J Hum Genet; 2020 Oct; 28(10):1341-1367. PubMed ID: 32616876
[TBL] [Abstract][Full Text] [Related]
18. Experience and outcome of 3 years of a European EQA scheme for genetic testing of the spinocerebellar ataxias.
Seneca S; Morris MA; Patton S; Elles R; Sequeiros J
Eur J Hum Genet; 2008 Aug; 16(8):913-20. PubMed ID: 18301445
[TBL] [Abstract][Full Text] [Related]
19. Enhanced Detection and Sizing of the HTT CAG Repeat Expansion in Huntington Disease Using an Improved Triplet-Primed PCR Assay.
Zhao M; Lee CG; Law HY; Chong SS
Neurodegener Dis; 2016; 16(5-6):348-51. PubMed ID: 27207688
[TBL] [Abstract][Full Text] [Related]
20. Huntington's disease: how intermediate are intermediate repeat lengths?
Squitieri F; Jankovic J
Mov Disord; 2012 Dec; 27(14):1714-7. PubMed ID: 23008174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]